PNC Financial Services Group’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
DTC
TCM
RCM
PNC Financial Services Group's ALT Position: Q2 2026 in Review
PNC Financial Services Group increased its Altimmune (ALT) stake by 149% in Q2 2026, buying an estimated $6.89K and bringing the position to 3,860 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4019.
PNC Financial Services Group first reported a position in ALT in Q4 2020 and has held it in 23 quarters since. The position peaked at $22.5K in Q1 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- PNC Financial Services Group held 3,860 shares of Altimmune worth $11.7K as of Q2 2026.
- PNC Financial Services Group bought 2,308 Altimmune shares in Q2 2026, an estimated $6.89K.
- Altimmune made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4019 holding.
- PNC Financial Services Group first reported a position in Altimmune in Q4 2020 and has held it in 23 quarters since.
- PNC Financial Services Group's Altimmune position peaked at $22.5K in Q1 2024.
- 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.